Pharmira Co., Ltd. is a Japanese pharmaceutical manufacturing company that provides CDMO services for APIs and intermediates. Pharmira specializes in continuous manufacturing of APIs through flow reaction equipment, flow synthetic process technology, and continuous crystallization modules. The company provides end-to-end services including scale-up R&D, trial manufacture by batch, raw materials, stability testing, and tech transfer. As of October 2025, the firm appears to be out of business.